SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Quidel snagged an emergency authorization from the FDA for what it describes as a rapid “ABC” test—a 15-minute, point-of-care diagnostic for influenza A, influenza B and COVID-19. The company’s Sofia ...
The stock's recent weakness is probably due to a high-profile case calling into question the specificity of Quidel's rapid antigen test. I explore the potential ...
SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Summer is time for camp—but it's also prime season for Lyme disease. That's the reminder from diagnostic maker Quidel, which has launched an awareness campaign highlighting the rise and risk of the ...
Easy-to-use test that provides results in 15 minutes is now available without a prescription The Sofia® SARS Antigen FIA shows excellent performance within the first five days of the onset of symptoms ...
Broadscale application of our Sofia® rapid antigen test for COVID-19 screening will catch asymptomatic cases early and limit virus spread.” The Sofia® SARS Antigen FIA is only for use under the Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results